Search
for
Sort by
Research 31–60 of 41
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
- The physical and physiological effects of vacuum massage on the different skin layers: a current status of the literature
- Combined drug triads for synergic neuroprotection in retinal degeneration
- Hydrogels: current biomedical applications and future directions
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Subject Index
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Chemically Induced Hair Loss/Alopecia
- ZALCITABINE
- NEW FORMULATIONS: Glatiramer acetate
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW PROPRIETARY BRANDS: Cefaclor monohydrate
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- The PDGF/PDGFR pathway as a drug target
- Drug Reactions Affecting Hair: Diagnosis
- Drug-Induced Hair Disorders
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis